cookies
policy:

This website uses cookies to ensure functionality for better navigation.
By continuing to browse, you consent to the use of cookies and the new terms and conditions of privacy.

I accept

Competence | quality | credibility

To meet our Partners’ Needs

LEF's Institutional video

highlights

Import of medicines

​​​Download the most recent newsletter to know how can we collaborate with your company in the import of medicines' area.

download

news

COVID 19: LEF, Hovione and Logoplaste hand in hand in support of Pharmacies

​​​In the context of the current pandemic outbreak LEF, Hovione and Logoplaste have joined forces to ensure additional supply to pharmacies of ethanol-based disinfectant solution, thus contributing by making available to pharmacies an important product for the preventive use of the spread of SARS-CoV-2 virus (COVID-19). Together we are stronger! #fightcovid19

COVID-19: Measures implemented at LEF

​​LEF, in compliance with the standards issued by the portuguese authorities, aims to maintain its normal functioning as far as possible, with the adoption of preventive and contingency measures. We have been making efforts to minimize the negative impacts on our busine​ss, customers, employees and other partners. Learn more about the set of measures implemented by LEF in the letter ​sent to all partners.

Nitrosamines - New deadline for risk assessment

​​​The deadline for submitting the results of drug products risk assessment containing chemically synthesized active substances (step 1) has been extended from 26 March to 1 October 2020! LEF has a customized consultancy service ready to answer this regulatory challenge.


Cannabis - Implementation of legal requirements

​​​​LEF has an integrated service offer for the medicinal cannabis market, assisting in the implementation of GACP, GMP, GDP and quality control analysis in accordance with current requirements. ​​​Contact LEF for more information!